ViiV registers two HIV studies: DDI trial for VH4011499 and NIAID-led PALACE trialNov 16Weekly roundup, 2 itemscabotegravirGilead Sciences
AstraZeneca-linked ovarian cancer trial posts results; myeloma follow-up study status reconfirmedNov 13Weekly roundup, 10 itemsAstraZenecaAZD0120Updated
Merck collaborator posts pancreatic cancer results; new MK-1045, COPD trial records surfaceNov 6Weekly roundup, 14 itemsDaiichi SankyoensifentrineUpdated
Sanofi's NKCE trial SAR443579 in AML halted early; results posted for terminated studyOct 23Weekly roundup, 6 itemsBayerdiclofenac
Lilly posts two DC-806 Phase 1 DDI results; registers three new Phase 3 trialsOct 22Weekly roundup, 11 itemscetuximabdulaglutide
Fred Hutchinson posts Phase II acalabrutinib results; AstraZeneca's AZD0780 LDL-C trial completesOct 16Weekly roundup, 11 itemsacalabrutinibAstraZenecaUpdated
Merck registers Phase 2b trial of tulisokibart for noninfectious uveitisOct 9Weekly roundup, 8 itemsglycopyrrolateMerck & Co., Inc.
Sanofi posts SAR444881 results; adds two rilzabrutinib trials and RSV AI studyOct 2Weekly roundup, 5 itemsrilzabrutinibSanofiUpdated
AstraZeneca-linked studies: OlympiaN, ZEAL and CHIO3 post results; two new studies registeredSep 25Weekly roundup, 7 itemsAstraZenecaAZD0120
BeOne Medicines registers Phase 1 drug interaction trial for CDK4 inhibitor BGB-43395Sep 15Trial updateBeiGene
Merck registers Phase 3 V503 HPV vaccine trial in Chinese females previously given 2vHPV shotAug 28Weekly roundup, 4 itemsbevacizumabDaiichi Sankyo
Glenmark wins FDA approvals for fluticasone nasal spray, rosuvastatin label updateAug 18Weekly roundup, 2 itemsfluticasoneGlenmark Pharmaceuticals
Madrigal advances MGL-2086 into Phase 1, adds resmetirom patents, posts Q2 2026 resultsJul 30Quarterly updateMadrigal Pharmaceuticals, Inc.resmetirom
FDA approves labeling supplement for Sun Pharma's generic rosuvastatin calcium tabletsJul 16Regulatory decisionrosuvastatinSun Pharmaceutical Industries